Long-term real-life glycaemic outcomes with a hybrid closed-loop system compared with sensor-augmented pump therapy in patients with type 1 diabetes.

Halis Kaan AkturkDominique GiordanoAnagha ChampakanathScott BrackettSatish GargJanet Snell-Bergeon

Published in: Diabetes, obesity & metabolism (2020)

The HCL system improved HbA1c levels and time-in-range, and decreased time spent in hypoglycaemia and hyperglycaemia at 6 months. Auto-mode use was significantly correlated with continuous glucose monitoring metrics and glycaemic outcomes.

Keyphrases

type diabetes
glycemic control
adipose tissue
skeletal muscle
weight loss
cell therapy